VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,472,442 | -30.5% | 2,147,243 | -1.8% | 0.02% | -28.1% |
| Q2 2023 | $40,984,819 | +77.9% | 2,185,857 | +36.8% | 0.03% | +88.2% |
| Q1 2023 | $23,043,073 | -3.1% | 1,597,994 | +30.1% | 0.02% | -10.5% |
| Q4 2022 | $23,770,449 | -10.8% | 1,228,447 | +58.4% | 0.02% | -13.6% |
| Q3 2022 | $26,645,000 | +1413.1% | 775,697 | +573.2% | 0.02% | +2100.0% |
| Q2 2022 | $1,761,000 | -32.7% | 115,232 | +62.4% | 0.00% | -50.0% |
| Q4 2021 | $2,616,000 | -29.0% | 70,950 | -9.5% | 0.00% | 0.0% |
| Q3 2021 | $3,686,000 | – | 78,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |